Scholar Rock Holding (SRRK) Amortizatization of Intangibles (2018 - 2026)

Scholar Rock Holding's (SRRK) quarterly Amortizatization of Intangibles came in at $169000.0 in Q1 2026, down 91.13% year-on-year from $1.9 million in Q1 2025, and down 14.65% quarter-over-quarter from $198000.0 in Q4 2025.

Scholar Rock Holding (SRRK) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends

Scholar Rock Holding's Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $169000.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 91.13% year-over-year to $169000.0 in Q1 2026; TTM through Mar 2026 was $2.3 million, a 57.31% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, down 24.61% from the prior year.
  • Amortizatization of Intangibles retreated to $169000.0 in Q1 2026 per SRRK's latest filing, from $198000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.9 million in Q1 2024 and bottomed at -$152000.0 in Q2 2022.
  • The 5-year median for Amortizatization of Intangibles is $1.3 million (2024), against an average of $1.0 million.
  • Across the five-year window, Amortizatization of Intangibles jumped 1598.18% in 2022 and sank 91.13% in 2026, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $1.6 million in 2022, then gained by 9.41% to $1.8 million in 2023, then dropped by 25.35% to $1.3 million in 2024, then plunged by 85.29% to $198000.0 in 2025, then decreased by 14.65% to $169000.0 in 2026.
  • Per Business Quant, the three latest SRRK Amortizatization of Intangibles figures stand at $169000.0 (Q1 2026), $198000.0 (Q4 2025), and $495000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Scholar Rock Holding 6.32 Bn 6.32 Bn - 169,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 169,000.00
Mar 31, 2026 169,000.00
Dec 31, 2025 198,000.00
Dec 31, 2025 198,000.00
Sep 30, 2025 495,000.00
Sep 30, 2025 495,000.00
Jun 30, 2025 1.39 Mn
Jun 30, 2025 1.39 Mn
Mar 31, 2025 1.91 Mn
Mar 31, 2025 1.91 Mn
Dec 31, 2024 1.35 Mn
Dec 31, 2024 1.35 Mn
Sep 30, 2024 709,000.00
Sep 30, 2024 709,000.00
Jun 30, 2024 1.32 Mn
Jun 30, 2024 1.32 Mn
Mar 31, 2024 1.92 Mn
Mar 31, 2024 1.92 Mn
Dec 31, 2023 1.80 Mn
Dec 31, 2023 1.80 Mn